
Poolbeg Pharma PLC (POLB.L)
POLB.L Stock Price Chart
Explore Poolbeg Pharma PLC interactive price chart. Choose custom timeframes to analyze POLB.L price movements and trends.
POLB.L Company Profile
Discover essential business fundamentals and corporate details for Poolbeg Pharma PLC (POLB.L) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
19 Jul 2021
Employees
15.00
Website
https://www.poolbegpharma.comCEO
Jeremy Skillington
Description
Poolbeg Pharma plc operates as a clinical stage infectious disease pharmaceutical company in the United Kingdom. It develops POLB 001, a p38 MAP Kinase inhibitor for the treatment of severe influenza; POLB 002, an inlicensed firstinclass intranasally administered RNAbased immunotherapy for respiratory virus infections; and POLB 003, an intramuscular vaccine to prevent Melioidosis. The company also has a licensed access to micro and nanoencapsulation technology to develop an oral vaccine delivery platform that delivers immune stimulating antigens to various areas of the gut; and artificial intelligence powered drug program. In addition, it is involved in the development of biomarker platform to identify those at risk of developing severe disease; and vaccine discovery platform, a model-derived discovery platform to identify new vaccine candidates. Poolbeg Pharma plc was incorporated in 2021 and is headquartered in London, the United Kingdom.
POLB.L Financial Timeline
Browse a chronological timeline of Poolbeg Pharma PLC corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 18 May 2026
Upcoming earnings on 16 Sept 2025
Earnings released on 20 May 2025
Earnings released on 18 Sept 2024
EPS came in at -£4.52 falling short of the estimated -£0.00 by -100.26K%.
Earnings released on 30 Apr 2024
EPS came in at -£4.28.
Earnings released on 13 Sept 2023
EPS came in at -£3.62.
Earnings released on 30 Mar 2023
EPS came in at -£6.16.
Earnings released on 6 Sept 2022
EPS came in at -£3.21 falling short of the estimated -£0.00 by -100.34K%.
Earnings released on 31 Dec 2021
EPS came in at -£2.34.
Earnings released on 30 Jun 2021
EPS came in at -£2.34.
POLB.L Stock Performance
Access detailed POLB.L performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.